Pink Ribbon Funding
The Kuijjer group has received funding from Pink Ribbon / the Norwegian Cancer Society to develop computational tools that integrate large-scale genome-wide regulatory networks with other `omics and clinical data, to help the discovery of new breast cancer subtypes and potential targets for personalized treatment of breast cancer. We are extremely excited to start this project in 2021. We will be collaborating with Vessela Kristensen's group at Oslo University Hospital and strengthen our collaboration with Kimberly Glass at the Channing Division of Network Medicine. For more information, please see the press release by Kreftforeningen (article in Norwegian) and NCMM.